Zdrowie i gospodarka · 27/10/1994

FDA Amends Notice for Joint Meeting of Advisory Committees

The FDA is updating the agenda for the joint meeting of the Nonprescription Drugs and Pulmonary-Allergy Drugs Advisory Committees, adding an extra topic to the open session and a closed session for the Nonprescription Drugs Advisory Committee, with no other changes.